Top Markets
#1 Derive Derive +33.82%
#2 Cross Cross +15.09%
#3 Geodnet Geodnet +13.37%
#4 Gama Token Gama Token +9.17%
#5 Talus Network Talus Network +8.96%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.42%
#7 Cap Cap +6.96%
#8 Audiera Audiera +5.78%
#9 OVERTAKE OVERTAKE +5.63%
#10 Ontology Gas Ontology Gas +5.54%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
StageZero Life Sciences Ltd. StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd.

SZLS
Rank in Stocks #36214
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Share Price
$0.02770208
Last synced: 2025-03-10
Market Cap
$2.92M
Change (1 day)
-0.46%
Change (1 year)
0.00%
Country
CA
Trade StageZero Life Sciences Ltd. (SZLS)

Category

Healthcare
Number of shares outstanding for StageZero Life Sciences Ltd. (SZLS)
Number of shares outstanding as of August 2026: 0
According to StageZero Life Sciences Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for StageZero Life Sciences Ltd. (SZLS) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M -
US